It’s officially Women’s Health Week, a full seven days dedicated to your well-being. While this may conjure images of joining a gym or eating more fruits and vegetables, a chance to be healthier could also be sitting right on your bathroom counter: beauty products. Instagram feeds are full of them and we, as women, can’t
The search for ways to improve uterine fibroid embolization () patient care is ongoing. From better pain management to cutting-edge imaging techniques, patient care is continually evolving to yield the best treatment results for women. This pursuit of improved patient care includes selecting an embolic material that gets superior results. A Scottish study revealed that
If you have fibroid-related heavy periods, you’re probably no stranger to feeling spent. And we’re not talking about the type of fatigue that comes with not having enough hours in the day. We’re talking about menstrual-related anemia. In fact, nearly half of women who suffer from both heavy periods and menstrual-related severe anemia were also
Uterine fibroids are frequently seen in the later reproductive years, especially during a woman’s 30s and 40s.1 These noncancerous tumors may not be an issue, but they can be the cause of serious symptoms, such as pelvic pain, heavy periods, and urinary frequency. For many of these women, finding a cure that also preserves fertility
Uterine fibroid embolization (UFE) is a well-established, minimally invasive fibroid treatment that’s recommended for select women who want to retain their uterus. Improving -related symptoms in 85%–90% of women treated, UFE targets fibroids of different sizes and locations in the uterus, relieving symptoms like heavy periods, pelvic pain, and urinary dysfunction.1 Watch a helpful video
More than 20 years ago, the first uterine fibroid embolization (ufe) was performed in the U.S. for the treatment of uterine fibroids.1 Although an effective alternative to hysterectomy, this uterine-sparing, minimally invasive option was first met with some skepticism by the medical community. Since then, ufe has grown in popularity—but not without a fight. Even
Practicing self-care is essential for a woman’s mental, emotional, and physical well-being. And yet, a recent Jean Hailes Women’s Health Survey found that more than one in four women aged 36-50 don’t get enough time to themselves each month.1 Between demands at work and home, finding that “me time” can be tough. It gets even
Uterine fibroids and polycystic ovary syndrome are two common reproductive health concerns for women. Both are hormone-related diseases that can affect the menstrual cycle, incite pelvic pain, and affect fertility. But beyond a few common symptoms and complications, are these two conditions linked? A landmark study found that among African American women, the incidence of
Women with uterine fibroids pay thousands of dollars more each year in health care costs compared to their healthy peers, a collection of studies show.1 Uterine fibroids, a non-cancerous tumor that grows within the muscle tissue of the uterus, affects nearly 70% of white women and more than 80% of black women by age 50.2
Up to half of women with uterine fibroids will seek treatment for bothersome symptoms like heavy periods, severe bloating, and painful sex.1 One such treatment is uterine fibroid embolization (UFE). An effective nonsurgical approach, UFE has shown to offer relief to nearly nine out of ten women treated.2 Despite these advantages, a downside to UFE
